Skip to main content

Smart Pills Market Upstream Process, Downstream Process Driving Factors by Manufacturers

Smart Pills Market are innovative ingestible medical devices that are finding application opportunities in areas such as diagnosis, drug delivery, and treatment by Application (Patient Monitoring and Others), Target Area (Esophagus, Small Intestine, and Others), Disease Indication (Disease Indication, and Others) End User (Hospitals and Others), Competitive Trends, Technology Growth, Industry Size, Global Opportunity and Development Scope —Forecast till 2023.
smart pills market size globally expected to get a substantial market share at an impressive CAGR of 14.2% during the review period.
The rising global geriatric population and growing prevalence of numerous types of chronic and acute disorders such as cancer, diabetes, and others, are influencing the growth of the smart pills market.
The key players identified in the global smart pills market are
FUJIFILM Holdings Corporation Inc.
MEDISAFE
MEDTRONIC
BDD Limited
Check-Cap
CapsoVision
INTROMEDIC
PENTAX Medical
JINSHAN Science & Technology
RF Co. Ltd. Inc.
Olympus Corporation
Proteus Digital Health
And Others.
Smart Pills Market Competitive Segments:
The global market for smart pills is segmented based on the target area, application, end-user, and disease indication.
Based on the target area, the market has been segmented into the esophagus, large intestine, stomach, and small intestine.
Based on the application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been sub-segmented into controllable capsule endoscopy, colon capsule endoscopy, small bowel capsule endoscopy, and others. The patient monitoring segment is sub-segmented into capsule pH monitoring and others. Bases on end-user, the market has been into the diagnostic center, hospitals, and research institute. Based on the disease indication, the market is segmented into colon diseases, esophageal diseases, small bowel diseases, and others.
Global Smart Pills Market: Regional Analysis
In the report, the market has been covered across Europe, Asia Pacific (APAC), North America, South America and the Middle East & Africa (MEA). North America and South America collectively hold the largest market share in terms of value. Factors such as rising incidence of chronic disorders, presence of robust reimbursement policies, rapid adoption of next-generation medical technologies are reflecting favorably on the region’s market. As per the organization Partnership to Fight Chronic Disease (PFCD) over 133 Mn people in the U.S have at least one chronic disease, which is equivalent to almost 45% of the total population. In the U.S., chronic diseases are also responsible for a sizable number of deaths.
Europe and Asia Pacific are the other two important market for smart pills. In Europe, factors such as high healthcare expenditure and increased focus on delivering effective healthcare is driving the growth of the market.
Meanwhile, the market in Asia Pacific is projected to witness the fastest growth during the forecast period. The market in MEA is also expected to register an impressive growth rate but from a smaller growth rate. The healthcare sector is undergoing tremendous transformation in the Middles East, which GCC countries such as Saudi Arabia, UAE and Qatar at the forefront.
Geographically, the global smart pills market has been covered across The Americas (North America and Latin America), the Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
Chapter 10. Global Smart Pills Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Contact Market Research Future:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...